ilmscore | 2 beaten down stocks with high ROCE | Market cap over ₹20,000 crores

2 beaten down stocks with high ROCE | Market cap over ₹20,000 crores

Published: 2024-12-08
Status: Available | Analyzed

Predictions from this Video

Total: 11
Correct: 0
Incorrect: 0
Pending: 11
Unrated: 0
Prediction
Topic
Status
Global Health (Medanta) plans to add 2,900 beds in the next 5 years, nearly doubling its capacity.
"Medanta will add 2,900 new beds in the next 5 years."
MEDANTA
Pending
Global Health (Medanta) plans to add 2,900 new beds within the next 5 years.
"Medanta will add 2,900 new beds in the next 5 years."
MEDANTA
Pending
Global Health (Medanta) plans an Rs 800 crore capex to nearly double its bed capacity.
"there is also a plan for a capex of Rs 800 crore with internal accrual and debt funding. This will nearly double the bed capacity."
MEDANTA
Pending
Global Health (Medanta)'s Noida hospital project is expected to be operational by Q1 2026, having been completed in Q1 2027 (note: there seems to be a typo in the transcript, assuming Q1 2026 operational date is intended).
"Vedanta's Noida hospital project has been completed on Q1 2027 and will be operational by Q1 2026."
MEDANTA
Pending
Global Health (Medanta)'s Noida hospital is expected to be operational by Q1 2026, with completion in Q1 2027.
"Vedanta's Noida hospital project has been completed on Q1 2027 and will be operational by Q1 2026."
MEDANTA
Pending
Global Health (Medanta) will manage a 750-bed Pitampura hospital over the next four years, requiring Rs 100 crore capex from Medanta.
"the company has also signed an operation and management agreement with the society and that will manage a 750-bed Pitampura hospital. This will be built in the next four years with a capex of Rs 100 crore from the Medanta side."
MEDANTA
Pending
Global Health (Medanta) will manage a 750-bed Pitampura hospital for the next four years, involving Rs 100 crore capex from Medanta.
"the company has also signed an operation and management agreement with the society and that will manage a 750-bed Pitampura hospital. This will be built in the next four years with a capex of Rs 100 crore from the Medanta side."
MEDANTA
Pending
Himadri Specialty Chemicals Limited will build a new manufacturing unit for lithium-ion battery components with an Rs 800 crore investment and 2 lakh MTPA capacity, with phase one operational by Q3 FY27.
"It will require an investment of Rs 800 crore and will have a capacity of 2 lakh MTPA. Its phase one will be operational by Q3 F27."
AACL
Pending
Himadri Specialty Chemicals (HSCL) anticipates 35% of its turnover from exports in the next 3 years.
"The company is expecting a turnover of about 35% through exports in the next 3 years."
HSCL
Pending
Himadri Specialty Chemicals Limited anticipates 35% of its turnover to come from exports within the next three years.
"The company is expecting a turnover of about 35% through exports in the next 3 years."
AACL
Pending
Himadri Specialty Chemicals (HSCL) will invest Rs 800 crore to build a lithium-ion battery components unit with a capacity of 2 lakh MTPA, with phase one operational by Q3 FY27.
"It will require an investment of Rs 800 crore and will have a capacity of 2 lakh MTPA. Its phase one will be operational by Q3 F27."
HSCL
Pending